Bio-Thera Solutions Has China’s First Adalimumab Biosimilar

Qletli Is Only The Second Biosimilar Approved In China

 
• By David Wallace
  
Thumbs_Up_China
China’s NMPA has approved Bio-Thera Solutions’ Adalimumab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products